Clinical trial
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease. An Open, Single Arm, Long-term Study
NCT01135368 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Lansoprazole in Patients With Reflux Disease. An Open, Single Arm, Long-term Study
- Lead sponsor
- Takeda
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- September 30, 2008
- Enrollment
- 506 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.